- Home
- DRMA vs FOXO Comparison
DRMA vs FOXO Comparison
Compare DRMA & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- FOXO
- Stock Information
- Founded
- DRMA 2014
- FOXO 2019
- Country
- DRMA United States
- FOXO United States
- Employees
- DRMA N/A
- FOXO 168
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- DRMA Health Care
- FOXO Technology
- Exchange
- DRMA Nasdaq
- FOXO Nasdaq
- Market Cap
- DRMA 4.5M
- FOXO 3.9M
- IPO Year
- DRMA 2021
- FOXO N/A
- Fundamental
- Price
- DRMA $0.75
- FOXO $0.08
- Analyst Decision
- DRMA Strong Buy
- FOXO
- Analyst Count
- DRMA 1
- FOXO 0
- Target Price
- DRMA $6.00
- FOXO N/A
- AVG Volume (30 Days)
- DRMA 4.2M
- FOXO 7.4M
- Earning Date
- DRMA 05-14-2025
- FOXO 04-15-2025
- Dividend Yield
- DRMA N/A
- FOXO N/A
- EPS Growth
- DRMA N/A
- FOXO N/A
- EPS
- DRMA N/A
- FOXO N/A
- Revenue
- DRMA N/A
- FOXO $4,051,601.00
- Revenue This Year
- DRMA N/A
- FOXO N/A
- Revenue Next Year
- DRMA N/A
- FOXO N/A
- P/E Ratio
- DRMA N/A
- FOXO N/A
- Revenue Growth
- DRMA N/A
- FOXO 2688.61
- 52 Week Low
- DRMA $0.69
- FOXO $0.07
- 52 Week High
- DRMA $6.17
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- DRMA 34.82
- FOXO 27.54
- Support Level
- DRMA $0.69
- FOXO $0.07
- Resistance Level
- DRMA $0.85
- FOXO $0.12
- Average True Range (ATR)
- DRMA 0.08
- FOXO 0.01
- MACD
- DRMA -0.00
- FOXO -0.00
- Stochastic Oscillator
- DRMA 21.43
- FOXO 17.72
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.